Reinach, Switzerland

Henning F Cierpka

This inventor holds 1 USPTO granted patent. Top assignee: Drossapharm Ag. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henning F Cierpka. Retrieved from https://idiyas.com/inventor/henning-f-cierpka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Henning F Cierpka

Introduction

Henning F Cierpka is a notable inventor based in Reinach, Switzerland. He has made significant contributions to the field of pharmacology, particularly through his innovative approaches to drug delivery systems. His work focuses on enhancing the efficacy of therapeutic agents, ensuring better patient outcomes.

Latest Patents

Cierpka holds a patent for a transdermal therapeutic system designed for the delivery of 5,6-benzo-alpha-pyrone. This invention addresses the limitations of oral administration of benzopyrone, which fails to achieve sufficiently high blood levels. The transdermal system allows for a controlled and sustained release of the drug, resulting in blood and tissue levels that are 50 times higher than those achieved through oral doses.

Career Highlights

Throughout his career, Cierpka has been associated with Drossapharm AG, where he has contributed to the development of innovative pharmaceutical solutions. His expertise in pharmacokinetics has been instrumental in advancing drug delivery technologies.

Collaborations

Cierpka has worked alongside Jurg Lutz, collaborating on various projects that aim to improve therapeutic systems and enhance drug efficacy.

Conclusion

Henning F Cierpka's contributions to the field of pharmacology through his innovative patent demonstrate his commitment to improving drug delivery methods. His work continues to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…